Clinical response to azacytidine (AZA) is associated with increased contribution from mutated blood progenitors: Insights from single cell genotyping of matched stem/progenitor and mature blood cells from MDS/CMML patients pre- and post-AZA treatment Meeting Abstract


Authors: Thoms, J. A. I.; Schnegg-Kaufmann, A.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E.; Failes, T. W.; Arndt, G. M.; Koval, J.; Davidson, S.; Lindeman, R.; Warburton, P.; Rodriguez-Meira, A.; Mead, A. J.; Unnikrishnan, A.; Hertzberg, M.; Polizzotto, M. N.; Papaemmanuil, E.; Bohlander, S. K.; Faridani, O.; Jolly, C. J.; Zanini, F.; Pimanda, J. E.
Abstract Title: Clinical response to azacytidine (AZA) is associated with increased contribution from mutated blood progenitors: Insights from single cell genotyping of matched stem/progenitor and mature blood cells from MDS/CMML patients pre- and post-AZA treatment
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 9751
End Page: 9752
Language: English
ACCESSION: WOS:000893230302326
DOI: 10.1182/blood-2022-163158
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors